Clinical validation of pharmacokinetic and pharmacodynamic models for propofol infusion. Comment on Br J Anaesth 2021; 126: 386-94.

Schnider, Thomas W; Minto, Charles F; Egan, Talmage D; Filipovic, Miodrag

Schnider, Thomas W; Minto, Charles F; Egan, Talmage D; Filipovic, Miodrag.

Afiliação

Schnider TW; Department of Anaesthesia, Intensive Care, Emergency and Pain Medicine, Kantonsspital, St. Gallen, Switzerland. Electronic address: thomas.schnider@kssg.ch.
Minto CF; Department of Anaesthesia, North Shore Private Hospital, Sydney, Australia.
Egan TD; Department of Anesthesiology, University of Utah, Salt Lake City, UT, USA.
Filipovic M; Department of Anaesthesia, Intensive Care, Emergency and Pain Medicine, Kantonsspital, St. Gallen, Switzerland.

Br J Anaesth ; 126(5): e172-e174, 2021 05.

Article em En | MEDLINE | ID: mdl-33685633

Assuntos

Propofol; Anestesia Geral; Anestésicos Intravenosos/farmacologia; Humanos; Propofol/farmacologia; Estudos Prospectivos; Remifentanil

Palavras-chave

model; pharmacodynamic; pharmacokinetic; propofol; target-controlled infusion

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propofol Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propofol Idioma: En Ano de publicação: 2021 Tipo de documento: Article